Evotec Names Joanna Holbrook Chief Scientific Officer and Management Board Member

• Evotec appointed Joanna Holbrook chief scientific officer and management board member, effective November 1, 2026.
• Holbrook most recently led cardiovascular, renal and hepatic disease research and in vitro discovery platforms at Novo Nordisk.
• She brings more than 25 years of experience and will lead the company's global scientific strategy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evotec SE published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2414804_en) on October 15, 2026, and is solely responsible for the information contained therein.